Skip to main content
. Author manuscript; available in PMC: 2018 May 12.
Published in final edited form as: ACS Infect Dis. 2017 Apr 6;3(5):368–377. doi: 10.1021/acsinfecdis.6b00214

Table 4.

Antimicrobial Data Against Wild Type and Engineered Strains of E coli Carrying Specific Resistance Determinants (MIC, μg/mL, (μM))a,b.

Strain BM13 (AG006) AG007 AG105 AG009 AG036 AG037
Resistance Mechanism Wild type AAC(3) AAC(2′) AAC(6′) ANT(4′, 4″) APH(3′, 5″)
Gentamicinc 0.5 (1) 32 (67) 32 (67) -d 0.5 (1) 0.25 (0.5)
Kanamycin Ac 1–2 (2–4) -d 1–2 (2–4) 128 (265) 16 (33) >256 (>530)
Tobramycinc 0.5 (1) -d -d 64 (137) 16 (34) 1 (2)
Neomycin 6 1 (2) 4 (7) 2 (3) 8 (13) 32 (52) >256 (>417)
22 1 (2) 2 (3) 2 (3) 16 (24) 32 (49) >256 (>389)
21 1 (2) 2 (3) 2 (3) 2 (3) 64 (97) >256 (>389)
28 4–8 (6–12) 16 (12) 4 (6) 16 (12) >64 (>24) >256 (>389)
30 1 (2) 2 (3) 2–4 (3–7) 64 (104) 128 (207) >256 (>414)
37 2–4 (3–6) 8–16 (12–23) 8 (12) 16 (23) 4 (6) >256 (>374)
11 0.5 (0.8) 2 (3) 2 (3) 32–64 (50–100) 0.5 (0.8) >256 (>399)
26 2 (3) 8 (11) -d 8–16 (11–23) >64 (>93) >256 (>364)
40 4 (5) 8 (11) -d 16–32 (22–44) 8 (11) >256 (>351)
a

All values were determined in duplicate using two dilution series.

b

MICs are given in μg/mL and in parentheses in μM.

c

These AGAs were used to verify the resistance phenotype type of the recombinant strains.

d

Not determined